Have a personal or library account? Click to login
Recomandările naționale ale Societății Croate de Biochimie și Medicină de Laborator pentru recoltarea, prelucrarea probelor de sânge, performanța testării și raportarea rezultatelor pentru testele screening de hemostază: timp de protrombină, timp de tromboplastină parțială activată, timp de trombină, fibrinogen și D-dimeri
Chandler WL, ed. Initial evaluation of hemostasis: reagent and method selection. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 63-71. DOI: 10.1002/9781444303575.ch7
Bronić A, Coen Herak D, Margetić S, Milić M. Policies and practices in haemostasis testing among laboratories in Croatia: a survey on behalf of a Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Biochem Med (Zagreb). 2017;27:199-216. DOI: 10.11613/BM.2017.022
Lippi G, Favaloro EJ, eds. Causes of errors in medical laboratories. In Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 22-31. DOI: 10.1002/9781118543467.ch3
Magnette A, Chatelain M, Chatelain B, Ten Cate H, Mullier F. Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories. Thromb J. 2016;14:49. DOI: 10.1186/s12959-016-0123-z
Nikolac N, Šupak-Smolčić V, Šimundić AM, Ćelap I. Croatian Society of Medical Biochemistry and Laboratory Medicine: national recommendations for venous blood sampling. Biochem Med (Zagreb). 2013;23:242-54. DOI: 10.11613/BM.2013.031
Suchsland J, Friedrich N, Grotevendt A, Kallner A, Lüdemann J, Nauck M, Petersmann A. Optimizing centrifugation of coagulation samples in laboratory automation. Clin Chem Lab Med. 2014;52:1187-91. DOI: 10.1515/cclm-2014-0038
Marlar RA, Potts MR, Marlar AA. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values. Am J Clin Pathol. 2006;126:400-5. DOI: 10.1309/RRQKT2JEYV33D19D
van Geest-Daalderop JH, Mulder AB, Boonman-de Winter LJ, Hoekstra MM, van den Besselaar AM. Preanalytical variables and off-Site blood collection: Influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy. Clin Chem 2005;51:561-8. DOI: 10.1373/clinchem.2004.043174
Favaloro EJ, Soltani S, McDonald J. Potential laboratory misdiagnosis of haemophilia and von Willebrand Disorder due to cold activation of blood samples for testing. Am J Clin Path. 2004;122;686-92. DOI: 10.1309/E4947DG48TVY19C2
Lima-Oliveira G, Adcock DM, Salvagno GL, Favaloro EJ, Lippi G. Mixing of thawed coagulation samples prior to testing: Is any technique better than another? Clin Biochem. 2016;49:1399-401. DOI: 10.1016/j.clinbiochem.2016.10.009
Gosselin RC, Honeychurch K, Kang HJ, Dwyre DM. Effects of storage and thawing conditions on coagulation testing. Int J Lab Hematol. 2015;37:551-9. DOI: 10.1111/ijlh.12342
Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M; British Committee for Standards in Haematology. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol. 2013;35:1-13. DOI: 10.1111/ijlh.12004
Kitchen S, Preston EF, Olson JD, eds. Internal Quality Control in the hemostasis Laboratory. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 57-64. DOI: 10.1002/9781118543467.ch6
Preston EF, Kitchen S, Srivastava A, eds. External Quality Assessment in Hemostasis: Its Importance and Significance. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 65-76. DOI: 10.1002/9781118543467.ch7
Clinical and Laboratory Standard Institute (CLSI). One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline-Second Edition H47-A2, Wayne: CLSI; 2008.
Tripodi A, ed. Monitoring Oral Anticoagulant Therapy. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 253-63. DOI: 10.1002/9781118543467.ch22
Bonar R, Favaloro EJ. Explaining and reducing the variation in inter-laboratory reported values for International Normalised Ratio. Thromb Res. 2017;150:22-9. DOI: 10.1016/j. thromres.2016.12.007
Clinical and Laboratory Standards Institute (CLSI). Procedures for Validation of INR and Local Calibration of PT/INR Systems; Approved Guideline. CLSI guideline H54-A. Wayne: CLSI; 2005.
Croatian Chamber of Medical Biochemists. [Harmonizacija laboratorijskih nalaza u području opće medicinske biokemije.] Available at: http://www.hkmb.hr/obavijesti/obavije-sti-index.html. Accessed March 21th 2016. (in Croatian).
Lippi G, Favaloro EJ. Activated partial thromboplastin time: New tricks for an old dogma. Semin Thromb Hemost. 2008;34:604-11. DOI: 10.1055/s-0028-1104539
Johnston M, ed. Monitoring Heparin Therapy. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 224-52. DOI: 10.1002/9781118543467.ch21
Brill-EdvardsP, Gunsberg JS, Johnston M, Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Intern Med. 1993;119:104-9. DOI: 10.7326/0003-4819-119-2-199307150-00002
Marlar RA, Gausman J. The optimum number and types of plasma samples necessary for an accurate activated partial thromboplastin time - based heparin therapeutic range. Arch Pathol Lab Med. 2013;137:77-82. DOI: 10.5858/arpa.2011-0516-OA
Laposata M, Green D, Van Cott EM, Barrowcliffe TW, Goodnight SH, Sosolik RC. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy; the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med. 1998;122:799-807
Mackie IJ, Kitchen S, Machin SJ, Lowe GDO. On Behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on fibrinogen assays. Br J Haematol. 2003;121:396-404. DOI: 10.1046/j.1365-2141.2003.04256.x
van den Besselaar AMHP, van Rijn CJJ, Cobbaert CM, Reijnierse GLA, Hollestelle MJ, Niessen R. et al. Fibrinogen determination according to Clauss: commutability assessment of International and commercial standards and quality control samples. Clin Chem Lab Med. 2017; 55:1761-9. DOI: 10.1515/cclm-2016-1088
Miesbach W, Schenk J, Alesci S, Lindhoff-Last E. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia. Thromb Res. 2010;126:e428-33. DOI: 10.1016/j.thromres.2010.09.004
Chitolie A, Mackie IJ, Grant D, Hamilton JL, Machin SM. Inaccuracy of the “derived” fibrinogen measurement. Blood Coagul Fibrinol. 1994;5:955-7. DOI: 10.1097/00001721-199412000-00012
Lippi G, Tripodi A, Simundic AM, Favaloro EJ. International survey on D-dimer test reporting: a call for standardization. Semin Thromb Hemost. 2015;41:287-93. DOI: 10.1055/s-0035-1549092
Clinical and Laboratory Standards Institute (CLSI). Quantitative D-Dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline H59-A. Wayne: CLSI; 2011.
Oude Elferink RFM, Loot AE, Van de Klashorst CGJ, Hulsebos-Huygen M, Piersma-Wichers M, Oudega R. Clinical evaluation of eight different D-dimer test for the exclusion of deep venous thrombosis in primary care patients. Scand J Clin Lab Invest. 2015;75:230-8. DOI: 10.3109/00365513.2014.993697
Douma RA, Tan M, Schutgens RE, Bates SM, Perrier A, Legnani C et al. Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica. 2012;97:1507-13. DOI: 10.3324/haematol.2011.060657
Favaloro EJ, Lippi G. Laboratory reporting of haemostasis assays: The final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis? Clin Chem Lab Med. 2010;48:309-21. DOI: 10.1515/CCLM.2010.061
Marlar RA, ed. Hemostasis test validation, performance, and reference intervals: international recommendations and guidelines. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 13-21. DOI: 10.1002/9781118543467.ch2
Ignjatovic V, Kenet G, Monagle P, on behalf of the Perinatal and Paediatric Haemostasis Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Developmental hemostasis: recommendations for laboratories reporting paediatric samples. J Thromb Haemost. 2012;10:298-300. DOI: 10.1111/j.1538-7836.2011.04584.x
Tripodi A, Lippi G, Plebani M. How to report results of prothrombin and activated partial thromboplastin times. Clin Chem Lab Med. 2016;54:215-22. DOI: 10.1515/cclm-2015-0657
Vasikaran S, Sikaris K, Kilpatrick E, French J, Badrick T, Osypiw J, Plebani M. IFCC WG harmonization of quality assessment of interpretative comments. Clin Chem Lab Med. 2016;54:1901-11. DOI: 10.1515/cclm-2016-0709
Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest. 2008;133:160S-98S. DOI: 10.1378/chest.08-0670
Pai M, Moffat KA, Plumhoff E, Hayward CM. Critical values in the coagulation laboratory: results of a survey of the North American Specialized Coagulation Laboratory Association. Am J Clin Pathol. 2011;136:836-41. DOI: 10.1309/AJCP8O8GIPPPNUSH
Don-Wauchope AC, Chetty VT. Laboratory defined critical value limits: how do hospital physicians perceive laboratory based critical values? Clin Biochem. 2009;42:766-70. DOI: 10.1016/j. clinbiochem.2009.02.016